EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent advances in hypoxia-activated compounds for cancer diagnosis and treatment

Xiaoyu Yuan, Zhiying Xie, Taotao Zou

Bioorganic Chemistry · 2024-03 · 144 · 107161

DOI: 10.1016/j.bioorg.2024.107161 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioorganic Chemistry, 2024-03. Verfasst von Xiaoyu Yuan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 51000…. Hauptthemen laut MEDLINE: Neoplasms, Prodrugs. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia, as a prevalent feature of solid tumors, is correlated with tumorigenesis, proliferation, and invasion, playing an important role in mediating the drug resistance and affecting the cancer treatment outcomes. Due to the distinct oxygen levels between tumor and normal tissues, hypoxia-targeted therapy has attracted significant attention. The hypoxia-activated compounds mainly depend on reducible organic groups including azo, nitro, N-oxides, quinones and azide as well as some redox-active metal complex that are selectively converted into active species by the increased reduction potential under tumor hypoxia. In this review, we briefly summarized our current understanding on hypoxia-activated compounds with a particular highlight on the recently developed prodrugs and fluorescent probes for tumor treatment and diagnosis. We have also discussed the challenges and perspectives of small molecule-based hypoxia-activatable prodrug for future development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsProdrugsHumansHypoxiaCell HypoxiaTumor HypoxiaCell Line, Tumor

Stichwörter der Autor:innen

Fluorescent probesProdrugTumor hypoxia

Substanzen

Prodrugs

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
  • Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China; Guangdong Provincial Key Laboratory of Functional Supramolec…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yuan, X., Xie, Z., & Zou, T. (2024). Recent advances in hypoxia-activated compounds for cancer diagnosis and treatment. Bioorganic Chemistry, 144, 107161. https://doi.org/10.1016/j.bioorg.2024.107161

Vancouver

Yuan X, Xie Z, Zou T. Recent advances in hypoxia-activated compounds for cancer diagnosis and treatment. Bioorganic Chemistry. 2024;144:107161. doi:10.1016/j.bioorg.2024.107161

BibTeX
@article{Yuan2024,
  author = {Yuan, Xiaoyu and Xie, Zhiying and Zou, Taotao},
  title = {Recent advances in hypoxia-activated compounds for cancer diagnosis and treatment},
  journal = {Bioorganic Chemistry},
  year = {2024},
  volume = {144},
  pages = {107161},
  doi = {10.1016/j.bioorg.2024.107161}
}
Kostenlos starten →